| 1 |
Prostheses Listing Advisory Committee |
| 2 |
Medical Technology Association of Australia (plus a supplementary
submission) |
| 3 |
Bard Australia Pty Ltd |
| 4 |
Matrix Surgical |
| 5 |
CONMED Linvatec Australia |
| 6 |
Australian and New Zealand Society for Vascular
Surgery |
| 7 |
Private Healthcare Australia |
| 8 |
Cochlear Limited |
| 9 |
Australian Diabetes Society and Endocrine Society of
Australia |
| 10 |
AMO Australia Pty Ltd |
| 11 |
Dr Janet Wale |
| 12 |
hirmaa |
| 13 |
Baxter |
| 14 |
Medibank Private Ltd |
| 15 |
AusBiotech Ltd |
| 16 |
nib health funds |
| 17 |
Royal Australasian College of Surgeons |
| 18 |
Reveale Surgical |
| 19 |
iNova Pharmaceuticals |
| 20 |
Department of Veterans’ Affairs |
| 21 |
Australian Orthopaedic Association |
| 22 |
Biotronik Australia Pty Ltd (plus a supplementary submission) |
| 23 |
Allergan |
| 24 |
Confidential |
| 25 |
Catholic Health Australia |
| 26 |
Australasian Medical and Scientific Ltd |
| 27 |
HBF Health Ltd |
| 28 |
HCF |
| 29 |
Stryker |
| 30 |
Alcon Laboratories (Australia) Pty Ltd |
| 31 |
Bupa |
| 32 |
Johnson and Johnson Medical Pty Ltd |
| 33 |
Consumers Health Forum of Australia |
| 34 |
Surgical Devices Pty Ltd |
| 35 |
LivaNova Australia |
| 36 |
Medtronic |
| 37 |
Independent Hospital Pricing Authority |
| 38 |
Department of Health |
| 39 |
Joint submission from four Australian medical device
manufacturers and distributors (plus two attachments and a supplementary
submission) |
| 40 |
Australian Medical Association |
| 41 |
Applied Medical (plus an attachment and a supplementary
submission) |
| 42 |
Healthscope |
| 43 |
Name Withheld (plus an attachment) |
| 44 |
hearts4heart |
| 45 |
Confidential |
| 1 |
Answers to Questions taken on Notice during 15 March public
hearing, received from Medtronic, 29 March 2017 |
| 2 |
Answers to Questions taken on Notice during 15 March public
hearing, received from Australian Medical Device Manufacturers and
Distributors group, 29 March 2017 |
| 3 |
Answers to Questions taken on Notice during 15 March public
hearing, received from Medical Technology Association of Australia, 29 March
2017 |
| 4 |
Answers to Questions taken on Notice during 15 March public
hearing, received from Johnson and Johnson Medical, 30 March 2017 |
| 5 |
Answers to Questions taken on Notice during 15 March public
hearing, received from Independent Hospital Pricing Authority, 3 April 2017 |
| 6 |
Answers to Questions taken on Notice during 16 March public
hearing, received from Department of Health, 27 March 2017 |
| 7 |
Answers to Questions taken on Notice during 16 March public
hearing, received from nib, 29 March 2017 |
| 8 |
Answers to Questions taken on Notice during 16 March public
hearing, received from Australian Private Hospitals Association, 29 March
2017 |
| 9 |
Answers to Questions taken on Notice during 16 March public
hearing, received from Private Healthcare Australia, 29 March 2017 |
| 10 |
Answers to Questions taken on Notice during 16 March public
hearing, received from AusBiotech, 29 March 2017 |
| 11 |
Answers to Questions taken on Notice during 16 March public
hearing, received from Department of Health, 30 March 2017 |
| 12 |
Answers to Questions taken on Notice during 31 March public
hearing, received from Medibank, 11 April 2017 |
| 13 |
Answers to Questions taken on Notice during 31 March public
hearing, received from Ramsay Health Care, 13 April 2017 |
| 14 |
Answers to Questions taken on Notice during 31 March public
hearing, received from Healthscope, 13 April 2017 |
| 15 |
Answers to written Questions on Notice, received from
Private Healthcare Australia, 20 April 2017 |
| 16 |
Answers to written Questions on Notice, received from
Medical Technology Association of Australia, 21 April 2017 |
| 17 |
Answers to written Questions on Notice, received from
Department of Health, 26 April 2017 |